Search

Search Results

• 

  Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

  Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

  27-07-2022

  3488

  PDF: 225

  Supplementary Files: 56
• 

  Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

  Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

  23-05-2022

  4624

  PDF: 185
• 

  A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

  Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

  09-03-2023

  329

  PDF: 196
• 

  Allopurinol-induced acquired von Willebrand syndrome

  Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad

  25-10-2023

  316

  PDF: 37
• 

  Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

  Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

  03-08-2023

  752

  PDF: 262
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  698

  PDF: 138

  Supplementary File: 41
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  666

  PDF: 234

  APPENDIX: 36
• 

  The new era of anticoagulation: factor XI and XII inhibitors

  Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

  07-06-2023

  912

  PDF: 429
• 

  Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

  Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

  17-10-2022

  2141

  PDF: 127
• 

  The metaphor of Ukrainian science “bleeding”

  Gaetano Torlone

  04-04-2023

  104

  PDF: 89
• 

  Well begun is half done

  Giovanni de Gaetano

  14-12-2022

  1421

  PDF: 86
• 

  Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

  Paolo Simioni, Vittorio Pengo, Paolo Prandoni

  07-11-2022

  1633

  PDF: 138
• 

  Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

  Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta

  15-04-2022

  371

  PDF: 134

  Supplementary Files: 35
• 

  Gene transfer in hemophilia B: a big step forward

  Giancarlo Castaman

  17-05-2023

  629

  PDF: 148
• 

  Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

  Paolo Prandoni

  11-10-2023

  290

  PDF: 55
• 

  How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

  Anna Falanga, Hugo Ten Cate, Bianca Rocca

  27-01-2023

  390

  PDF: 161
• 

  Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

  Mosaad Almegren

  12-10-2023

  38

  PDF: 23
• 

  Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

  Marco P. Donadini, Walter Ageno

  15-04-2022

  1805

  PDF: 387
• 

  Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond

  Cristina Santoro, Alessandro Casini

  03-08-2023

  699

  PDF: 110
• 

  The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

  Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

  26-04-2022

  1615

  PDF: 208